B. Braun Medical Inc., a prominent player in the medical technology industry, is headquartered in the United States, with significant operations across North America. Founded in 1839, the company has established itself as a leader in the development of innovative medical devices and pharmaceutical products, focusing on areas such as infusion therapy, pain management, and surgical instruments. Renowned for its commitment to quality and safety, B. Braun offers a diverse range of core products, including intravenous solutions, catheters, and anaesthesia equipment. The company’s unique approach combines advanced technology with a deep understanding of healthcare needs, positioning it as a trusted partner in patient care. With a strong market presence and a history of notable achievements, B. Braun continues to drive advancements in the medical field, enhancing outcomes for patients and healthcare professionals alike.
How does B. Braun Medical Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
B. Braun Medical Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
B. Braun Medical Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of B. Braun Holding GmbH & Co. KG, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from B. Braun Medical Inc. This lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate strategy. Given the increasing focus on sustainability within the medical industry, B. Braun Medical Inc. may benefit from aligning with industry standards and setting measurable targets to reduce its carbon footprint in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
B. Braun Medical Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.